Volume 82, Issue 11 , Pages 667-680.e6, November 2011
Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration:
The Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973
To access this article, please choose from the options below
Disclosure: The primary investigator is a consultant to Stereo Optical Company Inc. (Chicago, Illinois), manufacturer of the Functional Vision Analyzer, and to Annidis Health Systems (Ottawa, Ontario, Canada).
Richer SP, Stiles WR, Levin MR, et al. The zeaxanthin and visual function study in atrophic age related macular degeneration (ZVF-FDA IND #78, 973) - MP and foveal shape discrimination data, Poster #510. Presented at: The Association for Research in Vision and Ophthalmology Meeting; Ft Lauderdale, Florida; May 2, 2010.
This material is based on original work supported by the Captain James A. Lovell Federal Health Care Facility, North Chicago, Illinois, and the Department of Veterans Affairs Research Service/CARES (Hines, Illinois). Chrysantis, Inc. (West Chicago, Illinois) is the primary ZVF granting sponsor. Kowa Optimed, Inc. (Torrance, California and Tokyo, Japan), Stereo Optical, Inc. (Chicago, Illinois), Rush Ophthalmics, Inc. (Gold Beach, Oregon), Pharmanex, Inc. (Provo, Utah), ZeaVision, Inc. (Chesterfield, Missouri), Heidelberg Instruments, Inc. (Heidelberg, Germany), and RTVue (Fremont, California) all provided instrumentation as secondary sponsors in support of both ZVF and our Ocular Nutrition Laboratory.
PII: S1529-1839(11)00448-9
doi:10.1016/j.optm.2011.08.008
Published by Elsevier Inc.
Volume 82, Issue 11 , Pages 667-680.e6, November 2011
